SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,540.83 3.11
( 0.00%)

Global Indices

Nasdaq

53,294.39 514.18
(0.97%)

Dow Jones

7,693.51 31.35
(0.41%)

Hang Seng

65,893.13 -323.66
(-0.49%)

Nikkei 225

10,809.01 60.85
(0.57%)

Forex

USD-INR

95.67 0.05
(0.05%)

EUR-INR

111.76 0.57
(0.51%)

GBP-INR

130.35 0.55
(0.42%)

JPY-INR

0.60 0.00
(0.11%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Godavari Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530317

INE362C01012

71.053773

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

28.37

110.23

EPS(TTM)

Face Value()

Div & Yield %

3.56

Back

Caprihans India reports consolidated net loss of Rs 15.60 crore in the December 2025 quarter

Feb 11,2026

Net Loss of Caprihans India reported to Rs 15.60 crore in the quarter ended December 2025 as against net loss of Rs 18.56 crore during the previous quarter ended December 2024. Sales declined 8.21% to Rs 172.34 crore in the quarter ended December 2025 as against Rs 187.75 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	172.34	187.75	-8
OPM %	6.90	4.08	-
PBDT	-2.57	-8.96	71
PBT	-13.84	-19.98	31
NP	-15.60	-18.56	16

77,540.83 3.11 ( 0.00%)

53,294.39 514.18 (0.97%)

7,693.51 31.35 (0.41%)

65,893.13 -323.66 (-0.49%)

10,809.01 60.85 (0.57%)

95.67 0.05 (0.05%)

111.76 0.57 (0.51%)

130.35 0.55 (0.42%)

0.60 0.00 (0.11%)